You are here: Home : Chart
 |
|
| Pharmaceutical |
|
|
CFO Staff,
CFO Magazine
|
|
|
PHARMACEUTICAL |
| Company
Name |
Sales
($ Mill.) |
DWC |
DWC
Change Over Last Year |
DWC 3
Year Ave. |
DPO |
DPO
Change Over Last Year |
DPO 3
Year Ave. |
Inven-
tory Turns |
Inven-
tory Turns Change Over Last Year |
Inven-
tory Turns 3 Year Ave. |
DSO |
DSO
Change Over Last Year |
DSO 3
Year Ave. |
CCE |
CCE 3
Year Ave. |
|
ELI LILLY AND COMPANY |
$11,543 |
58 |
-4 |
63 |
20 |
-3 |
20 |
2 |
0 |
2 |
44 |
-10 |
50 |
32% |
31% |
|
SCHERING-PLOUGH CORP. |
$9,802 |
62 |
12 |
50 |
40 |
2 |
40 |
2 |
0 |
2 |
67 |
14 |
54 |
26% |
25% |
|
BRISTOL-MYERS SQUIBB CO. |
$19,423 |
72 |
-4 |
76 |
30 |
-4 |
33 |
4 |
1 |
3 |
74 |
1 |
73 |
28% |
26% |
|
JOHNSON & JOHNSON |
$33,004 |
53 |
-13 |
62 |
31 |
5 |
28 |
3 |
0 |
3 |
51 |
-5 |
54 |
27% |
24% |
|
MERCK & CO, INC. |
$47,716 |
28 |
-5 |
31 |
39 |
-3 |
42 |
8 |
1 |
7 |
40 |
-8 |
44 |
19% |
19% |
|
PFIZER INC. |
$32,259 |
74 |
-7 |
78 |
18 |
-4 |
21 |
2 |
0 |
2 |
60 |
-8 |
67 |
29% |
24% |
|
ALLERGAN, INC. |
$1,685 |
64 |
-10 |
71 |
23 |
0 |
22 |
4 |
0 |
4 |
61 |
-7 |
64 |
21% |
21% |
|
WATSON PHARMACEUTICALS INC. |
$1,161 |
84 |
23 |
86 |
50 |
-40 |
60 |
2 |
1 |
2 |
54 |
16 |
62 |
17% |
11% |
|
IVAX CORP. |
$1,215 |
121 |
-10 |
123 |
29 |
6 |
27 |
2 |
0 |
2 |
74 |
3 |
70 |
16% |
13% |
|
PHARMACIA CORP. |
$13,837 |
81 |
-47 |
129 |
28 |
4 |
31 |
2 |
1 |
1 |
64 |
-8 |
88 |
14% |
12% |
|
WYETH |
$14,129 |
99 |
-3 |
102 |
17 |
1 |
17 |
2 |
0 |
2 |
71 |
-5 |
73 |
-31% |
-4% |
|
PHARMACEUTICAL Average |
$16,888 |
72 |
-6 |
79 |
30 |
-3 |
31 |
3 |
0 |
3 |
60 |
-2 |
64 |
18% |
18% |
|
|
|
